Inhibition of Reverse Transcriptase as A Clue for Curing RNA Viral Infections
Author(s):
Shimon Shatzmiller*, Ludmila Buzhansky, Inbal Lapidot, Galina Zats and Rami Krieger
Scientists provide evidence showing that delayed chain discontinuation is a plausible mechanism of action of Remdesivir. This mechanism was described previously in the context of reverse transcriptase (RT) inhibition of human immunodeficiency virus type 1 (HIV-1) and hepatitis B virus